Researchers are utilizing a combination of AI and 'Ramanomics' to observe living cancer cells in real-time, potentially overcoming major hurdles in pharmaceutical research.
The new chip-based technology allows scientists to monitor cellular responses to drugs with unprecedented precision, significantly accelerating the drug discovery pipeline.
Experts believe this innovation could reduce the time and cost required to develop targeted cancer therapies by providing more accurate data on how cells interact with new compounds.